- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
A Prevenar 13 leavepiece prominently linked HIV to a “New Indication”, implying a licensed HIV indication and omitting…
A pharmacist said an Almirall COPD guidelines meeting invite blurred education vs promotion. PMCPA ruled the invite/meeting were…
Roche alleged Merck Serono breached a prior PMCPA undertaking via a Cancer Drugs Fund presentation of Erbitux trial…
An NHS chief pharmacist alleged a Strattera nurse speaker contract looked like inducement/seeding research and queried disclosure. PMCPA…
Anonymous GP alleged an MSD representative brought her daughter to meetings. MSD found no record of any complaint.…
Toujeo iPad “Latest Data” app design and training encouraged linking clamp-study PK/PD variability data to reduced hypoglycaemia. Panel…
A PCT adviser challenged AstraZeneca’s Symbicort budget impact presentation to GP practice managers and meeting sponsorship. Panel found…
PMCPA case AUTH/3006/12/17 (Director v Lilly) concerning clinical trial disclosure for Trulicity. Outcome: No breach; matter was outwith…
Complaint alleged Facebook/Twitter meeting adverts lacked sponsorship statements and reached the public. Panel initially found a Clause 22.4…
PMCPA case AUTH/2188/12/08: complaint about conduct of a representative. The matter was ruled outwith the scope of the…
One real case. One key lesson. Every week — free.